MedTrace Logo

Empirical Rescue Therapies of Helicobacter Pylori Infection

NCT01668927 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 424

Last updated 2013-06-04

No results posted yet for this study

Summary

The increase of antibiotic resistance to H. pylori causes failure of treatment. Furazolidone, amoxicillin and tetracycline are good candidates for rescue therapy since resistance to these three antimicrobials was rare. It is necessary to assess the efficacy and safety of these four bismuth-containing quadruple regimens with above antibiotics as empirical rescue therapies for H. pylori eradication.

Conditions

  • Functional Dyspepsia
  • Scarred Peptic Ulcer

Interventions

DRUG

Proton Pump Inhibitor

DRUG

Bismuth

DRUG

Metronidazole

DRUG

Tetracycline

DRUG

Furazolidone

DRUG

Amoxicillin

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-09-30
Completion
2012-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01668927 on ClinicalTrials.gov